OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Combined company will have market value of around $18 billion, reports Reuters.
reported today that contract medical research provider Quintiles agreed to merge with healthcare information company IMS Health in a deal worth about $9 billion. The combined company will have a market value of nearly $18 billion and will offer drug and medical device makers services. After the deal, IMS Health shareholders will own about 51.4 percent of the combined company, while Quintiles shareholders will own the rest. The new company - Quintiles IMS Holdings Inc - will be led by IMS Health Chief Executive Ari Bousbib, while Quintiles CEO Tom Pike will be the vice chairman. The deal is expected to close in the second half of 2016. For more see here: